"What else do you have to do that will actually have to affect the Iranians' calculus?" said Amos Hochstein, who served as U.S. special envoy for international energy affairs...World Politicsread more
Reports of tensions may have been sparked by Kraft Heinz's underperformance, and because of accounting problems at the packaged goods company.Investingread more
The leaders of Japan and China got off to a tense start but have made significant progress in turning around their relations in recent years.Asia Politicsread more
Tech's hottest IPOs of the year, including Beyond Meat and Zoom, dropped on Monday, falling more than the broader market.Technologyread more
Citi Private Bank says it has maintained an "overweight" stance on stocks in China, Hong Kong, Taiwan and South Korea.Asia Marketsread more
FedEx sued the U.S. government, saying it should not be held liable if it inadvertently shipped products that violated a Trump administration ban on exports to some Chinese...Traderead more
SpaceX used its high speed boat called "Ms. Tree" to catch the nosecone its Falcon 9 rocket after Monday's launch.Investing in Spaceread more
Stocks in Asia slipped on Tuesday, while investors looked toward a meeting between U.S. President Donald Trump and Chinese President Xi Jinping set to happen later in the...Asia Marketsread more
A week of dovish fireworks out of the central banking community has just gone by with most of the world's leading central banks now guiding towards easing in light of downside...Commentaryread more
"We do not seek conflict with Iran or any other country," Trump tells reporters in the Oval Office.Politicsread more
Chinese Vice Premier Liu He held a phone conversation with U.S. Trade Representative Robert Lighthizer and U.S. Treasury Secretary Steven Mnuchin, China's Ministry of Commerce...World Economyread more
The Department of Justice is close to approving CVS Health's acquisition of Aetna and Cigna's acquisition of Express Scripts, The Wall Street Journal reported Wednesday, citing people familiar with the matter.
Both deals could receive formal antitrust approval as soon as the next few weeks, the people told the Journal.
Regulators will require CVS and Aetna to sell off assets related to its Medicare drug coverage in order to appease competitive concerns surrounding the nearly $70 billion deal, people familiar with the deliberations told The Wall Street Journal. One potential buyer in talks for the assets is WellCare Health Plans, though discussions between CVS, Aetna and the Justice Department are still ongoing, people told the paper.
A CVS spokeswoman pointed to comments CVS CEO Larry Merlo made last month on a call with Wall Street analysts. He said the company "contemplated a range of possibilities" in the Medicare Part D business, where both CVS and Aetna offer plans. He said they "determined the impact of any divestitures would not be material to the deal model."
An Aetna spokesman said the company does not have comment.
Meanwhile, Cigna's $54 billion acquisition of Express Scripts could be approved without any asset sales, people familiar with the deal review told the Journal.
An Express Scripts spokesman said the company continues "to constructively work with the Department of Justice" and remains "confident the deal will close by the end of the year."
A Cigna spokeperson said the company continues to "work cooperatively with the DOJ and the states to discuss the many benefits of the Express Scripts transaction and remains confident that the merger will close by year-end 2018."
The Justice Department declined to comment.
Shares of CVS gained 0.9 percent Wednesday, while shares of Aetna gained 1.6 percent. Cigna shares slid 0.6 percent, while shares of Express Scripts surged 4 percent.